Researchers from the Vanderbilt University, the University of Toronto and Chronix Biomedical have demonstrated a method for detecting ‘cell-free’ tumour DNA in the bloodstream.  The team believe that the technique will be transformative in providing improved cancer diagnostics that can both predict treatment outcomes and monitor patient responses to therapy. In a large retrospective study of blood samples, the researchers showed that the method, called … Continue reading Researchers develop epigenetic ‘cell-free’ DNA blood test for prostate cancer.